Center for Scientific Review; Notice of Closed Meetings, 16640 [2020-06096]
Download as PDF
<![CDATA[
16640
Federal Register / Vol. 85, No. 57 / Tuesday, March 24, 2020 / Notices
Dated: March 18, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
lotter on DSKBCFDHB2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR:
Exosomes and SUDs.
Date: April 3, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Peter B. Guthrie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4142,
MSC 7850, Bethesda, MD 20892, (301) 435–
1239, guthriep@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Molecular and Cellular Mechanisms
of Neuropathologies.
Date: April 6, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Peter B. Guthrie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4142,
MSC 7850, Bethesda, MD 20892, (301) 435–
1239, guthriep@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
VerDate Sep<11>2014
17:34 Mar 23, 2020
Jkt 250001
[FR Doc. 2020–06096 Filed 3–23–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2014–0022]
Technical Mapping Advisory Council
Federal Emergency
Management Agency, DHS.
ACTION: Committee management; notice
of Federal Advisory Committee meeting.
AGENCY:
The Federal Emergency
Management Agency (FEMA) Technical
Mapping Advisory Council (TMAC) will
hold a virtual meeting on Tuesday,
April 14, 2020, and Wednesday, April
15, 2020. The meeting will be open to
the public via an Adobe Connect link
and conference line.
DATES: The TMAC will meet on
Tuesday, April 14, 2020, and
Wednesday, April 15, 2020, from 8:00
a.m. to 5:30 p.m. Eastern Time (ET).
Please note that the meeting will close
early if the TMAC has completed its
business.
SUMMARY:
The meeting will be held
virtually using an Adobe Connect link
(https://fema.connectsolutions.com/
tmacmeeting) to share meeting visuals
and a conference line number (1–800–
320–4330 Pin: 875873#) to connect to
the audio of the meeting. Members of
the public who wish to attend the
virtual meeting must register in advance
by sending an email to FEMA–TMAC@
fema.dhs.gov (Attention: Michael
Nakagaki) by 5:00 p.m. ET on Monday,
April 13, 2020. For information on
facilities or services for individuals with
disabilities or to request special
assistance at the meeting, contact the
person listed below as soon as possible.
To facilitate public participation,
members of the public are invited to
provide written comments on the issues
to be considered by the TMAC, as listed
in the SUPPLEMENTARY INFORMATION
section below. Associated meeting
materials will be available at
www.fema.gov/TMAC for review by
Friday, April 10, 2020. Written
comments to be considered by the
committee at the time of the meeting
must be submitted and received by
Monday, April 13, 2020, identified by
Docket ID FEMA–2014–0022, and
ADDRESSES:
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
submitted by one of the following
methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Email: Address the email TO:
FEMA–TMAC@fema.dhs.gov. Include
the docket number in the subject line of
the message. Include name and contact
information in the body of the email.
• Mail: Regulatory Affairs Division,
Office of Chief Counsel, FEMA, 500 C
Street SW, Room 8NE, Washington, DC
20472–3100.
Instructions: All submissions received
must include the words ‘‘Federal
Emergency Management Agency’’ and
the docket number for this action.
Comments received will be posted
without alteration at https://
www.regulations.gov, including any
personal information provided.
Docket: For docket access to read
background documents or comments
received by the TMAC, go to https://
www.regulations.gov and search for the
Docket ID FEMA–2014–0022.
A public comment period will be held
on Tuesday April 14, 2020, from 12:00
p.m. to 12:30 p.m. ET and Wednesday
April 15, 2020, from 12:00 p.m. to 12:30
p.m. ET. Speakers are requested to limit
their comments to no more than three
minutes. The public comment period
will not exceed 30 minutes. Please note
that the public comment period may
end before the time indicated, following
the last call for comments. Contact the
individual listed below to register as a
speaker by close of business on Monday,
April 13, 2020.
FOR FURTHER INFORMATION CONTACT:
Michael Nakagaki, Designated Federal
Officer for the TMAC, FEMA, 400 C
Street SW, Washington, DC 20024,
telephone (202) 212–2148, and email
michael.nakagaki@fema.dhs.gov. The
TMAC website is: https://www.fema.gov/
TMAC.
SUPPLEMENTARY INFORMATION: Notice of
this meeting is given under the Federal
Advisory Committee Act, 5 U.S.C. App.
In accordance with the Biggert-Waters
Flood Insurance Reform Act of 2012, the
TMAC makes recommendations to the
FEMA Administrator on: (1) How to
improve, in a cost-effective manner, the
(a) accuracy, general quality, ease of use,
and distribution and dissemination of
flood insurance rate maps and risk data;
and (b) performance metrics and
milestones required to effectively and
efficiently map flood risk areas in the
United States; (2) mapping standards
and guidelines for (a) flood insurance
rate maps, and (b) data accuracy, data
quality, data currency, and data
eligibility; (3) how to maintain, on an
E:\FR\FM\24MRN1.SGM
24MRN1
]]>Agencies
[Federal Register Volume 85, Number 57 (Tuesday, March 24, 2020)]
[Notices]
[Page 16640]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06096]
[[Page 16640]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR: Exosomes and SUDs.
Date: April 3, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Peter B. Guthrie, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4142, MSC 7850, Bethesda, MD
20892, (301) 435-1239, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Molecular and Cellular Mechanisms of
Neuropathologies.
Date: April 6, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Peter B. Guthrie, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4142, MSC 7850, Bethesda, MD
20892, (301) 435-1239, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: March 18, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-06096 Filed 3-23-20; 8:45 am]
BILLING CODE 4140-01-P
